When Clinical and Metabolomics Data Work Together: A Comparative Framework for Multimodal Disease Classification across Machine and Deep Learning.
7 affiliations
- 1Siriraj Center of Research Excellence in Metabolomics and Systems Biology (SiCORE-MSB), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
- 2Siriraj Metabolomics and Phenomics Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
- 3Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
- 4Thailand Metabolomics Association, Bangkok 10700, Thailand.
- 5Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand.
- 6Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
- 7Center of Excellence for Innovation in Chemistry (PERCH-CIC), Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Abstract
Disease classification using clinical and metabolomics data increasingly relies on multimodal integration, yet the complementary and comparative contributions of these modalities remain poorly understood. Most existing frameworks prioritize predictive performance without systematically examining how data modalities and modeling paradigms influence classification outcomes. Consequently, the relative value of individual modalities versus their integration, particularly in terms of model behavior, robustness, and interpretability, remains poorly characterized across machine learning (ML) and deep learning (DL) approaches. Here, we present a modality-aware comparative framework that enables direct, side-by-side evaluation of clinical-only, metabolomics-only, and combined modeling strategies within a unified pipeline. Unlike existing tools designed primarily for multiomics integration, this framework explicitly assesses when and how each modality contributes value across diverse classification scenarios. It supports the efficient use of available data while enabling a systematic comparison of model performance, stability, and interpretability across ML and DL methods. Rather than introducing a new classifier model, this work delivers a unified benchmarking workflow for evidence-based decision-making of modeling strategies in small-sample clinical metabolomics settings. Applied to two glomerulonephritis cohorts representing clinically-driven and metabolomics-driven classification settings, the framework revealed that the dominant contributing modality shifted by scenario, reflecting differences in disease context. These scenarios reflect realistic situations where discriminative signals arise from clinical variables, metabolic alterations, or their combination, as well as more complex cases involving subclass discrimination with overlapping profiles. While several models achieved comparable predictive accuracy, they differed in feature ranking stability, sampling sensitivity, and tendency to overfitting. Overall, this framework facilitates transparent, evidence-based selection of modeling strategies and data modalities suited to data complexity, sample size, and research objectives. Source code is available at https://github.com/kwanjeeraw/MMFramework.
Related
- Metabolomics workbench: data-driven classification and correlation analysis between metabolite classes, biomarkers, and drugs.
- Metabolomics for Athlete Monitoring: An Evidence-Readiness Framework for Contextual Validation
- Spatial metabolomics-guided deep learning framework for dissecting immune evasion mechanisms in fungal infection microenvironments
- Comparative metabolomics of serum and serum extracellular vesicles of melanoma and triple-negative breast cancer utilizing biobank samples
- TLQ Method: A Tandem Mixing-Linear Deduction-Quantile Weighted Median Framework for Robust Differential Metabolite Screening in LCMS-Based Untargeted Metabolomics
BibTeX
@article{wanichthanarak2026when,
title = {{When Clinical and Metabolomics Data Work Together: A Comparative Framework for Multimodal Disease Classification across Machine and Deep Learning.}},
author = {Kwanjeera Wanichthanarak and Kassaporn Duangkumpha and Nichapa Kleebkomut and Pairash Saiviroonporn and Trongtum Tongdee and Yongyut Sirivatanauksorn and Chagriya Kitiyakara and Sakda Khoomrung},
journal = {ACS measurement science au},
year = {2026},
month = aug,
doi = {10.1021/acsmeasuresciau.6c00108},
url = {https://europepmc.org/article/MED/42921086},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - When Clinical and Metabolomics Data Work Together: A Comparative Framework for Multimodal Disease Classification across Machine and Deep Learning.
AU - Kwanjeera Wanichthanarak
AU - Kassaporn Duangkumpha
AU - Nichapa Kleebkomut
AU - Pairash Saiviroonporn
AU - Trongtum Tongdee
AU - Yongyut Sirivatanauksorn
AU - Chagriya Kitiyakara
AU - Sakda Khoomrung
PY - 2026
DA - 2026/08/11
JO - ACS measurement science au
DO - 10.1021/acsmeasuresciau.6c00108
UR - https://europepmc.org/article/MED/42921086
AB - Disease classification using clinical and metabolomics data increasingly relies on multimodal integration, yet the complementary and comparative contributions of these modalities remain poorly understood. Most existing frameworks prioritize predictive performance without systematically examining how data modalities and modeling paradigms influence classification outcomes. Consequently, the relative value of individual modalities versus their integration, particularly in terms of model behavior, robustness, and interpretability, remains poorly characterized across machine learning (ML) and deep learning (DL) approaches. Here, we present a modality-aware comparative framework that enables direct, side-by-side evaluation of clinical-only, metabolomics-only, and combined modeling strategies within a unified pipeline. Unlike existing tools designed primarily for multiomics integration, this framework explicitly assesses when and how each modality contributes value across diverse classification scenarios. It supports the efficient use of available data while enabling a systematic comparison of model performance, stability, and interpretability across ML and DL methods. Rather than introducing a new classifier model, this work delivers a unified benchmarking workflow for evidence-based decision-making of modeling strategies in small-sample clinical metabolomics settings. Applied to two glomerulonephritis cohorts representing clinically-driven and metabolomics-driven classification settings, the framework revealed that the dominant contributing modality shifted by scenario, reflecting differences in disease context. These scenarios reflect realistic situations where discriminative signals arise from clinical variables, metabolic alterations, or their combination, as well as more complex cases involving subclass discrimination with overlapping profiles. While several models achieved comparable predictive accuracy, they differed in feature ranking stability, sampling sensitivity, and tendency to overfitting. Overall, this framework facilitates transparent, evidence-based selection of modeling strategies and data modalities suited to data complexity, sample size, and research objectives. Source code is available at https://github.com/kwanjeeraw/MMFramework.
SN - 2694-250X
ER -